Any feedback?
Please rate this page
(literature.php)
(0/150)

BRENDA support

Literature summary extracted from

  • Sujino, K.; Jackson, R.J.; Chan, N.W.C.; Tsuji, S.; Palcic, M.M.
    A novel viral alpha2,3-sialyltransferase (v-ST3Gal I) transfer of sialic acid to fucosylated acceptors (2000), Glycobiology, 10, 313-320 .
    View publication on PubMed

KM Value [mM]

EC Number KM Value [mM] KM Value Maximum [mM] Substrate Comment Organism Structure
2.4.3.6 0.11
-
 8-methoxy-8-oxooctyl beta-D-Gal-(1->4)-beta-D-GlcNAc pH and temperature not specified in the publication myxoma virus

Organism

EC Number Organism UniProt Comment Textmining
2.4.3.2 myxoma virus Q9YJT3
-
-
2.4.3.6 myxoma virus Q9YJT3
-
-

Purification (Commentary)

EC Number Purification (Comment) Organism
2.4.3.2
-
 myxoma virus
2.4.3.6
-
 myxoma virus

Substrates and Products (Substrate)

EC Number Substrates Comment Substrates Organism Products Comment (Products) Rev. Reac.
2.4.3.2 CMP-N-acetylneuraminate + beta-D-Gal-(1->3)-beta-D-GalNAc-R broad substrate specificity, the viral enzyme utilizes disaccharides type I-III and also fucosylated Lewis a and Lewis x myxoma virus CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->3)-beta-D-GalNAc-R
-
 ?
2.4.3.6 CMP-N-acetyl-beta-neuraminate + 8-methoxy-8-oxooctyl beta-D-Gal-(1->4)-beta-D-GlcNAc
-
 myxoma virus CMP + 8-methoxy-8-oxooctyl alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc
-
 ?
2.4.3.6 CMP-N-acetylneuraminate + beta-D-Gal-(1->4)-beta-D-GalNAc-R type II disaccharides are preferred substrates myxoma virus CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GalNAc-R
-
 ?
2.4.3.6 CMP-N-acetylneuraminate + beta-D-Gal-(1->4)-beta-D-GlcNAc i.e. N-acetyllactosamine myxoma virus CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc
-
 ?
2.4.3.6 CMP-N-acetylneuraminate + beta-D-Gal-(1->4)-beta-D-GlcNAc-R broad substrate specificity, the viral enzyme utilizes disaccharides type I-III and also fucosylated Lewis a and Lewis x myxoma virus CMP + alpha-Neu5Ac-(2->3)-beta-D-Gal-(1->4)-beta-D-GlcNAc-R
-
 ?